Pharmacogenomics Course

22
Lessons
2
Exams
11
Quizzes
16 hrs
Est. Course Time

The 16-hour RxGenomix Training Program in Pharmacogenomics is a self-paced course designed to help working pharmacists learn about the science of pharmacogenomics and how it may be applied in their clinical practice. Course content addresses the genetic basis for individual differences in metabolizing enzymes, transporters, and other biochemicals impacting drug disposition and action that underpin the practice of precision (personalized) medicine. 

The course is a combination of self-study and recorded program activity, provided entirely online. The program consists of two modules:

  • Module One focuses on the science of pharmacogenomics and gives healthcare providers, especially pharmacists, the background science needed in this area.
  • Module Two focuses on the application of pharmacogenomics in clinical practice and establishes the pharmacist’s capabilities to apply and implement the science into practice.

Testing within each program module will ensure students have a thorough knowledge of each section before advancing. The course includes both a midterm exam and a final exam, scored by percentage. 

The RxGenomix Training Program in Pharmacogenomics has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Pharmacy Education (ACPE) through the joint providership of CEImpact (CEI) and RxGenomix. CEI is accredited by the ACPE to provide continuing education for pharmacists.

Pre-registration is required. There is a fee of $349 to participate, which includes a digital copy of the companion textbook for the course.

For more information, including how to offer the course at your college of pharmacy, call us today at (615) 814-2911 or email info@rxgenomix.com.

At the completion of this activity, pharmacists and pharmacy technicians will be able to:

  1. Define pharmacogenetics (PGt), pharmacogenomics (PGx), and the related nomenclature.
  2. Explain the scientific basis of genetic influence on pharmacokinetics (PK) and pharmacodynamics (PD) related to drug and/or drug dose selection.
  3. Describe the types of DNA samples for PGt/PGx testing.
  4. Interpret PGt/PGx test results.
  5. Identify drug-gene and drug-drug-gene interactions in medication lists.
  6. Associate genetic and non-genetic factors which define a patient’s phenotype relative to response to medication therapy.
  7. Recommend specific alternative therapies and/or doses of specific medications based on PGt/PGx results.
  8. Relate pharmacist competencies in PGt/PGx to science and application.

FACULTY

David Bright, PharmD, BCACP
Associate Professor of Pharmacy
Ferris State University

David Kisor, PharmD
Chair, Department of Pharmaceutical Sciences
Director, Master of Science in Pharmacogenomics Program
Manchester University

Brad Tice, PharmD, MBA, FAPhA
Founder and Shareholder, RxGenomix

DISCLOSURES

David Bright, PharmD, BCACP declares financial interests for the following:

RelationshipName of Commercial InterestReceived
Co-investigatorGenemarkers, LLCHonorarium
Principal InvestigatorRiteAidFunded research

David Kisor, PharmD declares financial interests for the following:

RelationshipName of Commercial InterestReceived
PGx Education ConsultantPWN Health, LLCConsulting fee
Author-Pharmacogenetics, Kinetics, and Dynamics for Personalized MedicineJones & Bartlett LearningRoyalties

Brad Tice, PharmD, MBA, FAPhA declares financial interests for the following:

RelationshipName of Commercial InterestReceived
FounderRxGenomix, LLCShareholder

ACCREDITATION INFORMATION

CEI is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). The following course is approved for 16.0 contact hour of CPE credit (1.6 CEUs). The ACPE Universal Activity Number for this activity is: 0107-9999-19-337-H01-P (pharmacists).

Available: October 26, 2019
Expiration Date: October 25, 2022

To obtain 16.0 contact hours of CPE credit for completing this course, “Pharmacogenomics,” participants must pre-register online, participate in the entire course, pass the final exam with a score of at least 70%, and complete the CPE assessment and evaluation questions.

ON DEMAND: To obtain 16.0 contact hours of continuing pharmacy education credit (1.6 CEUs), participants must pre-register for the course on the RxGenomix website (rxgenomix.com), complete the entire on-demand course, and pass the mid and final exams with scores of at least 70%.  Once completed, you will receive a code from RxGenomix and instructions on how to access the evaluation on the CEImpact LMS . Once the evaluation is successfully completed, click the Submit button. The CPE Statement of Credit can then be accessed on CPE Monitor, www.MyCPEMonitor.net.

TARGET AUDIENCE
  • Pharmacists
ACPE ACTIVITY TYPE

Knowledge-based

ACTIVITY FEE

There is a fee of $349 associated with this activity.

DEVELOPMENT

“Pharmacogenomics” is a home study continuing education activity for pharmacists developed by RxGenomix.

SYSTEM REQUIREMENTS

The RxGenomix learning portal is designed to work with any current web browser. If you have any technical difficulties, please contact RxGenomix: info@rxgenomix.com. For best results, the following system capabilities are recommended:

WINDOWS
  • Windows XP, Windows 2003 or Windows Vista
  • Display resolution of 800×600 or higher
  • Microsoft Internet Explorer 6.0 SP1 or later, Firefox 2.0 or later, or Google Chrome 1.0
  • For Firefox and Chrome, Silverlight 1.0 or later
  • Windows Media Player 9.0 or later
  • Broadband Internet connection (256 Kbps or more)
  • No network blocks or filters that disable streaming media
MAC
  • Mac OS X 10.5 or later
  • Safari 2.0.4 or later (or Firefox 2.0 or later) Silverlight 1.0
  • Broadband Internet connection (256 Kbps or more)
  • No network blocks or filters that disable streaming media.